Tests:HbA1c (POCT): Difference between revisions
Tests:HbA1c (POCT)
No edit summary |
No edit summary |
||
| Line 14: | Line 14: | ||
|'''Synonyms''' | |'''Synonyms''' | ||
|HbA1c whole blood (POCT) | |HbA1c whole blood (POCT) | ||
glycated haemoglobin | |||
HBA | |||
|- | |- | ||
|'''Availability''' | |'''Availability''' | ||
|Cobas b101 HbA1c devices are available at both Taranaki Base and Hawera hospital. | |Cobas b101 HbA1c devices are available at both Taranaki Base and Hawera hospital. | ||
|- | |- | ||
|'''Turnaround Time''' | |'''Turnaround Time''' | ||
| | |6 minutes from placing cartridge into analyser with patients' blood sample | ||
|- | |- | ||
|'''Stability – Add test''' | |'''Stability – Add test''' | ||
| | |60 seconds once blood sample has been applied to cartridge disc. | ||
EDTA samples within 2 hours from collection | |||
Lithium-Heparin within 8 hours from collection | |||
|- | |- | ||
! colspan="2" | | ! colspan="2" | | ||
| Line 36: | Line 38: | ||
|- | |- | ||
|'''Acceptable''' | |'''Acceptable''' | ||
| | |Purple top (EDTA) or Lithium-Heparin, non-gel (green top) | ||
|- | |- | ||
|'''Unacceptable''' | |'''Unacceptable''' | ||
|Samples | |Samples containing anticoagulants or other additives | ||
Separated samples | Separated samples | ||
|- | |- | ||
|'''Minimum Volume''' | |'''Minimum Volume''' | ||
| | |2µL whole blood | ||
|- | |- | ||
|'''Specimen Collection and Transportation''' | |'''Specimen Collection and Transportation''' | ||
| Line 54: | Line 54: | ||
|- | |- | ||
|'''Test Method''' | |'''Test Method''' | ||
| | |Cobas b101 - ROCHE analyser | ||
|- | |- | ||
|'''Unit of Measurement''' | |'''Unit of Measurement''' | ||
| mmol/ | | mmol/mol | ||
|- | |- | ||
|'''Reference Intervals''' | |'''Reference Intervals''' | ||
| | |Non-diabetic reference interval 20-40 mmol/mol. | ||
Risk of microvascular complications increases exponentially above 55 mmol/mol. | |||
If >/= 50 mmol/mol and not known to have diabetes, a repeat level >/= 50 after an interval supports the diagnosis. | |||
If result is >65 mmol/mol, consider additional action. | |||
|- | |- | ||
|'''Uncertainty of measurement''' | |'''Uncertainty of measurement''' | ||
| Line 66: | Line 71: | ||
|- | |- | ||
|'''Additional Information''' | |'''Additional Information''' | ||
| | |Ranges of measurement 20-130mmol/mol | ||
The presence of some haemoglobin variants may require testing via alternative methods for HbA1c or the laboratory may refer clinician to glucose based criteria for diagnosis and monitoring. | |||
|- | |- | ||
! colspan="2" | | ! colspan="2" | | ||
== '''Comments''' == | == '''Comments''' == | ||
|- | |- | ||
| colspan="2" |Quick user guides for testing should be available with the | | colspan="2" |Quick user guides for testing should be available with or near the analysers. | ||
All procedures, worksheets and competency checklist for | All procedures, worksheets and competency checklist for sign-off are available on the intranet to all Health NZ Staff. | ||
|} | |} | ||
{{DocMeta | {{DocMeta | ||